All eyes are on this season’s new developments in ILD management and diagnosis.
Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

The IPF Cell Atlas
Launched: November 22, 2019

Senescence, Senolytics, and IPF
Launched: November 13, 2019

 
 

The PRECISIONS Study
Launched: November 13, 2019

Genomics and Transcriptomics in PF
Launched: November 13, 2019

 
 

Recent Findings from PF Registries
Launched: November 13, 2019

Recent Developments in IPF Diagnosis
Launched: November 13, 2019

 
 

Evaluating Pulmonary Rehab Added on to Antifibrotic Therapy
Launched: November 13, 2019

New Developments in Clinical Trials of Pulmonary Fibrosis
Launched: November 13, 2019

 

 
 

Antifibrotic Therapy in Patients w/Autoimmune-Associated ILD
Launched: November 13, 2019

Evaluating Gene Expression of Alveolar Macrophages and SAECs
Launched: November 13, 2019

 

 
 


Expanding the Use of Antifibrotic Therapy in Patients with PF

Launched: November 22, 2019

Considerations for the Management of Autoimmune-Related ILD and Chronic Hypersensitivity-Related ILD
Launched: November 22, 2019

 

 
 

Key Takeaways from Recent Pulmonary Conferences
Launched: November 13, 2019

Download Audio